Introduction
Globally, about 240 million people are reported to be affected by chronic Hepatitis B Virus (HBV) infection and 185 million people by Hepatitis C Virus (HCV) infection (1, 2) . Despite the recent global decrease in the prevalence of Hepatitis B, according to a recent analysis the rate of deaths from liver complications associated with hepatitis B has increased by 33% from 1990 to 2013, (3) . HCV infection is a major public health problem globally. To be able to establish evidence-based health policies and to wisely use the resources, it is vital to know the epidemiology of HCV infection and its disease burden (4) . HBV and HCV is transmitted by infected blood and other body fluids, and acquired through parenteral, sexual, horizontal, nosocomial and perinatal contact (2, 5) . In Turkey, the prevalence of HBV infection is reported to be 4% and of HCV infection 1%, with variations among regions (6) .
Healthcare workers (HCWs) are exposed to numerous infectious agents because of their profession. Individuals working in the operation room, the intensive care unit, the laboratories and the emergency room are in contact with infected patient materials such as blood and other body fluids, which causes them to be more frequently exposed to agents transmitting blood-borne diseases. According to data of the World Health Organization (WHO), more than 85 million people working in hospitals worldwide are injured by contaminated medical instruments (7) . Evidence shows that mentally disabled persons are at higher risk of Human Immunodeficiency Virus (HIV), Hepatitis B and Hepatitis C infections than the general population. These patients have less knowledge about how infectious diseases are acquired and which protective measures should be taken. Moreover, they may engage in risky sexual behaviors, and maintain below-average life and hygiene standards. These may constitute the factors that increase transmission risk among mentally disabled individuals (8) .
As previous studies report higher rates for the eastern regions of Turkey compared to the western regions, in this study we aimed to investigate whether awareness of patients in an eastern region of Turkey had an effect on the prevalence of the viral hepatitis and compared the awareness levels of two high-risk groups with different cognitive abilities.
Materials and Methods
The study was conducted in the eastern city of Elazığ and included HCWs from the state district hospital and individuals staying in a State Care and Rehabilitation Center for the Mentally Disabled (SCRCMD). Approval was obtained from the Ethics Committee of Fırat University for the study (approval number: 03/20, date: 07.02.2019). The study was designed in line with the Ethical Principles for Medical Research Involving Human Subjects set forth by the World Medical Association in the Declaration of Helsinki.
Hepatitis B surface antigen (HBsAg), anti-HBs, anti-hepatitis A virus (HAV)-immunoglobulin G (IgG), anti-HCV and HIV seropositivity data of the patients recorded from 1 January 2016 to 31 December 2018 were retrospectively examined. Patients with a recurrent condition were excluded. HBsAg, Anti-HBs, anti-HAV-IgG, anti-HCV and HIV serological values were tested using the Chemiluminescent Microparticle Immunoassay method on an Architect i2000 SR (Abbott, USA) device. In the HCV-positive patients, HCV-RNA levels were measured by real time Polymerase chain reaction using Rotor-Gene Q analyser (Qiagene, Hilden, Germany). HBsAg positive patients were divided into two groups, the chronic infection group and the chronic hepatitis group, based on their HBV-DNA levels, HBeAg positivity/negativity, ALT levels, and liver histology, as recommended in the EASL 2017 guidelines (9) . Follow-up and treatment processes of the patients were planned as recommended in EASL 2017 guidelines.
Statistical Analysis
The data were analyzed using the SPSS 22.0 package program. The Pearson chi-square test was used for inter-group variables, and a p<0.05 value was considered as the limit of significance.
Results
Of the 102 HCWs included in the study 56 (54.9%) were male and 46 (45.09%) were female, with an age range from 21 to 53 (mean: 33.96±8.53 years). All 110 individuals in the SCRCMD group were male with an age range from 20 to 71 (mean: 50.60±11.04 years). The HCWs group included 41 (40.1%) nurses-midwives, 16 (15.6%) doctors, 16 (15.6%) health technicians (anesthesia technician, health officer), 14 (13.7%) laboratory technicians, 12 (11.7%) cleaning personnel, and 3 (2.9%) ambulance drivers.
Two (2%) of the HCWs were HBsAg positive, 93 (91.2%) were anti-HBs-positive, and 85 (83.3%) were anti-HAV-IgG positive, however, none were anti-HCV or HIV-positive. One of the two HCWs diagnosed with chronic Hepatitis B was a nurse and the other a cleaning personnel. No statistically significant differences were identified between HBsAg and anti-HAV-IgG positivity based on occupation groups; however, anti-HBs positivity was found to be significantly lower in the cleaning personnel compared to the other HCWs (p=0.002) ( Table 1) .
Of the individuals in the SCRCMD group, 8 (7.3%) were HBsAgpositive, 61 (55.5%) were anti-HBs-positive, 95 (86.4%) were anti-HAV-IgG-positive, and 1 (0.9%) was anti-HCV positive. None was identified to be HIV positive. Comparison of the HCWs group and the SCRCMD group showed no statistically significant differences for HBsAg, anti-HAV-IgG and anti-HCV positivity, but significantly lower anti-HBs positivity in the SCRCMD group (p<0.001) ( Table 1) .
Of the two HBsAg-positive individuals in the HCWs group, one was receiving treatment with oral antivirals for chronic hepatitis and had negative HBV-DNA, and the other was monitored for chronic infection. Of the eight HBsAg positive individuals in the SCRCMD group, one was receiving antiviral treatment and had negative HBV-DNA. Evaluation of laboratory values showed chronic infection in four patients and follow-up processes were planned. Three patients were evaluated to have chronic hepatitis and started on oral antivirals. One anti-HCV positive patient had previously received treatment and had negative HCV-RNA.
Discussion
In our study, anti-HBs positivity was identified as 91.2% in the HCWs group and 55.5% in the SCRCMD group. The lowest anti-HBs positivity level in the HCWs group was identified in the cleaning personnel (53.1%). Seropositivity rates of the groups are seen to be in line with the education and awareness levels of the individuals.
In 1992 WHO and International Labor Organization have acknowledged HBV as an occupational disease factor (10) . In 1996, the Turkish Ministry of Health initiated a practice requiring the examination and, if necessary, the vaccination of HCWs against this virus (11) . A study carried out by the European Centre for Disease Prevention and Control in European countries, reported the lowest rate for HBsAg positivity among the general population in the Netherlands and Ireland (0.1%), and the highest in Turkey (9%). The same study reported the lowest rate for anti-HCV positivity in Belgium (0.1%) and the highest in Italy (22.4%) (12) .
HBV infection in HCWs occurs by contact with blood rather than by contact with the patients. Supporting HCWs, in particular, not only are in direct contact with patients but often come into contact with infected blood and other similar materials (13) . Although lumen needles are often held responsible for documented HCV infection events, such infection can be transmitted via blood splash into conjunctiva or lumenless needles. Despite such risks, the prevalence of HCV infection among HCWs is not higher than that of the general population. Only 1-2% of all needle accidents experienced by the HCWs are reported to be caused by needles used in HCV-infected patients (14) . Recent studies have shown that HCV infection could be eliminated in 15-20 years through diagnosis, treatment and strategies toward preventing new cases. To be able to develop the strategies that will eliminate HCV infection, however, it is important to clearly understand the epidemiology of the disease (15, 16) .
As is the case across the world, improvement in hygiene and sanitation conditions leads to progress in socio-economic conditions, and decrease in HAV circulation among children, as well as an increase in the number of sensitive adults, and the slow progression of the disease in advanced ages (17) . Hepatitis A prevalence is closely related to the indicators of socio-economic development levels, particularly to geographical differences, hygiene and other health conditions (18) . Turkey has intermediate endemicity with data showing a prevalence of 8-88%. Increase in the mean age for exposure to the virus has raised the number of adolescents and adults who are mindful of the condition in areas of intermediate endemicity (19) .
A study conducted in South Korea with 571 HCWs, reported HBsAg positivity to be 2.4% and anti-HBs positivity 76.9%, and that these rates were not different from that of the general population (20) . In another study conducted with 601 HCWs, HBsAg positivity was found 1.8%, and anti-HBs positivity 51.4%; and anti-HBs positivity was identified in laboratory technicians (63.6%), doctors (62.7%), nurses (52%) and cleaning personnel (40%) (21) .
In a study conducted in Turkey with HCWs, HBsAg positivity of 5.8% was identified among 14.000 HCWs in the years from 1980 to 1990, and of 3.6% from 1990 to 2000; and this decrease was found statistically significant (22 (26) , on the other hand, reported HBsAg positivity to be 0.9%, anti-HBs positivity 86% and found the lowest anti-HBs positivity values among the cleaning personnel. Another study reported HBsAg positivity to be 1% and anti-HBs positivity 62.7%. This study reported the highest anti-HBs positivity values in doctors (95%) and the lowest anti-HBs positivity values in cleaning personnel (43.86%) (22) . In our study, HBsAg positivity among HCWs was found 2% and anti-HBs positivity 91.2%. The highest anti-HBs positivity was found among nurses (95.3%) and the lowest among cleaning personnel (53.1%). These rates are comparable to the results reported in the literature. That the lowest anti-HBs rate among HCWs was identified in the cleaning personnel may be associated with education and awareness. In a study conducted with HCWs of five hospitals in the same country, anti-HCV positivity was found to be 2% (21) . Anti-HCV positivity among HCWs in Turkey is reported to range from 0% to 0.34% (11, 22, 25, 26) . Similarly, no anti-HCV and HIV positivity was identified among HCWs in our study. Kurugol et al. (27) report anti-HAV-IgG positivity among the by general population in Turkey to be 85.83% for the 20-29 age group, 95.6% for the 30-39 age group, and 99% for the +40-age group. Korkmaz et al. (26) found an anti-HAV-IgG positivity rate of 71.7% among HCWs. In our study, we identified anti-HAV-IgG positivity in 85 out of 102 HCWs (83.3%). WHO recommends Hepatitis A vaccination in regions of intermediate endemicity, where the number of mindful adults with a severely progressing disease is seen to increase parallel to the improvements in sanitation conditions (18) . In our study, vaccination was recommended to HCWs who were identified to be seronegative for Hepatitis A.
A study, in which 5.227 mentally disabled individuals were evaluated, HBsAg positivity was reported to be 4.08%, anti-HBs positivity 42.19%, anti-HCV positivity 0.69%, while no anti-HIV positivity was identified (28) . In our study, HBsAg positivity was found 7.3%, anti-HBs positivity 55.5%, anti-HCV positivity 0.9% in the SCRCMD group. HIV positivity was not identified. Although proportional difference was found in HBsAg positivity between the HCWs group and in the SCRCMD group, this difference was not statistically significant. This may be a result of the small number of our sample size. We believe that studies with larger-scale samples are needed. No statistically significant differences were identified in anti-HBs positivity between the two groups (p=0.000).
Study Limitations
The limitation of our study was the low number of cases and reflecting local data.
Conclusion
To conclude, that anti-HBs positivity was found lower for the cleaning personnel, individuals possibly of lower educational levels compared to other HCWs, and in the SCRCMD group, emphasizes the importance of differences in cognitive abilities an aspect we have considered when planning and designing our study. Individuals that fall in risk groups should be carefully examined for seropositivity and non-immune individuals should be included in Hepatitis B and Hepatitis A vaccination programs. We believe that hepatitis infection rates can be reduced in risk groups, especially among individuals with lower cognitive awareness, through more effective infection control measures and more frequent vaccination.
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